SCHEMBL3940869

SCHEMBL3940869

O=C(O)Cc1cccc(C2CCCN(S(=O)(=O)c3cc(Cl)cc(Cl)c3)C2)c1

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.49
PTGDR2 Q9Y5Y4 2/20 0.48
BCL9 O00512 7/20 0.47
CTNNB1 P35222 7/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ITGA4 P13612 1/20 0.42
AKR1C3 P42330 1/20 0.42
SLC13A5 Q86YT5 1/20 0.41
USP5 P45974 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3941097 0.93 PTGDR2 (0.51) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL4110985 0.92 SMN1; SMN2 (0.48) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL3941700 0.89 BCL9 (0.54) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL3941279 0.88 BCL9 (0.46) CNR1BCL9CTNNB1MEN1KMT2A
SCHEMBL3928445 0.88 BCL9 (0.47) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL3941517 0.86 MAPT (0.55) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL14366755 0.86 MEN1 (0.48) BCL9CTNNB1MEN1KMT2AAKR1C3
SCHEMBL3932070 0.86 ALDH1A1 (0.50) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL3929084 0.86 MAPT (0.55) PTGDR2BCL9CTNNB1MEN1KMT2A
SCHEMBL3938045 0.86 MAPT (0.55) PTGDR2BCL9CTNNB1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044017-A2 SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS ICOS CORPORATION (US) 2009-04-08 EP disclosed
WO-2007146838-A2 SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS ICOS CORPORATION (US) 2007-12-21 WO disclosed
WO-2007146838-A2 SUBSTITUTED PHENYL ACETIC ACIDS AS DP-2 ANTAGONISTS ICOS CORPORATION (US) 2007-12-21 WO disclosed